American College of Clinical Pharmacy
      Search      Cart
         

ACSAP 2023 Book 2 Geriatric and Pediatric Care


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to receive multi-book discounts at the member rate. Your ASHP membership number and expiration date are required.

The latest release in ACCP’s popular Ambulatory Care Self-Assessment Program (ACSAP) features comprehensive reviews, timely updates, and interactive cases on ambulatory care topics with a focus on pediatric and older adult populations. The target audience for ACSAP 2023 Book 2 (Geriatric and Pediatric Care) is board-certified and advanced level clinical pharmacists who provide care for geriatric and pediatric patients in ambulatory care settings.

Krystal Kay Craig Riccio, Pharm.D., BCACP, CDCES
Riccio

The book contains four learning modules with a total available 16.0 continuing pharmacy education (CPE) credits. The content of Geriatric and Pediatric Care was developed under the leadership of Faculty Panel Chair Krystal Kay Craig Riccio, Pharm.D., BCACP, CDCES.

Chapters in the first module provide updates on the management of diabetes and hypertension in older adults. The second module focuses on caring for pediatric patients, with updates in pain management, depression and bipolar disorders, and juvenile idiopathic arthritis. The third module includes chapters covering geriatric syndromes and arthritis in older adults. The fourth module is comprised of three interactive cases on co-occurring attention-deficit/hyperactivity disorder (ADHD) and anxiety, prescribing and deprescribing in older adults, and fall prevention and osteoporosis in older adults.

Each ACSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Interactive cases (a series of webpages, each introduced by a sample case-based question)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

ACSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Release Date: July 17, 2023
BCACP Deadline: January 16, 2024
ACPE Deadline: July 17, 2026

ISBN: 978-1-952291-78-4
Publication Year: 2023
Format: PDF and ePub

Contents

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 1

Chapter: Diabetes Management in Older Adults
Chapter: Hypertension Management in Older Adults

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 2

Chapter: Pain Management in Pediatric Patients
Chapter: Depression and Bipolar Disorder in Adolescence
Chapter: Rheumatology: Juvenile Idiopathic Arthritis

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 3

Chapter: Geriatric Syndromes
Chapter: Arthritis in Older Adults: Osteoarthritis, Rheumatoid Arthritis, and Gout

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 4

Interactive Case: Attention-Deficit/Hyperactivity Disorder and Anxiety
Interactive Case: Prescribing Cascades/Deprescribing in Older Adults
Interactive Case: Fall Prevention and Osteoporosis in Older Adults

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCACP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: The target audience for ACSAP 2023 Book 2 (Geriatric and Pediatric Care) is board-certified and advanced level clinical pharmacists who provide care for geriatric and pediatric patients in ambulatory care settings.

Contents

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 1

Activity Number: 0217-9999-23-103-H01-P
Contact Hour(s): 4.00
Activity Type: Application Based
Learning Objectives

Chapter: Diabetes Management in Older Adults

  1. Classify the incidence of diabetes and possible complications in older adults with diabetes.
  2. Distinguish the role of fingerstick and continuing glucose monitoring in older adults with diabetes.
  3. Construct a comprehensive monitoring plan for diabetes and possible diabetes-related complications for a given patient scenario.
  4. Design a comprehensive medical nutritional therapy and physical activity plan for older adults given patient scenarios.
  5. Plan appropriate therapy for an older adult with diabetes with any of the following: reduced renal function, high risk of hypoglycemia, or cardiometabolic needs.
  6. Construct a pharmacotherapy regimen minimizing the risk of adverse effects.
  7. Compose a comprehensive diabetes management plan for given scenarios of older adults with comorbidities.
  8. Assess the unique social determinants of health (SDOH) of older adults with diabetes.
  9. Design a treatment plan addressing a specific SDOH of health. 

Chapter: Hypertension Management in Older Adults

  1. Analyze the incidence of hypertension (HTN) and possible complications in older adults with HTN.
  2. Analyze guidelines and recent evidence for HTN and blood pressure goals in older adults.
  3. Devise the appropriate assessment for diagnosis and management of HTN in older adults.
  4. Construct a comprehensive monitoring plan for HTN and possible HTN-related complications for given patient scenarios.
  5. Develop a comprehensive nonpharmacologic plan including diet and physical activity changes for given patient scenarios.
  6. Design a plan using appropriate medications for older adults living with HTN and for those with comorbidities of chronic kidney disease, diabetes, heart failure, stroke, or stable ischemic heart disease while minimizing the risk of adverse effects. 

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 2

Activity Number: 0217-9999-23-104-H01-P
Contact Hour(s): 5.00
Activity Type: Application Based
Learning Objectives

Chapter: Pain Management in Pediatric Patients

  1. Distinguish between the different classifications of pain according to type, source, location, and severity.
  2. Detect the presence of pain, assess severity, and develop a treatment approach to manage pain in a preverbal, verbal, or nonverbal child with or without neurologic impairment.
  3. Design a prevention and treatment regimen for a pediatric patient using nonpharmacologic and pharmacologic approaches according to the pain severity or circumstance.
  4. Resolve medication administration and dose modification issues for pediatric patients and enhance appropriate medication use during care transitions.
  5. Devise a monitoring plan to assess treatment goals, identify tolerance, and prevent physical dependency and withdrawal.
  6. Justify the importance of interdisciplinary pain teams and institutional pain protocols or guidelines in improving pain outcomes in pediatric patients. 

Chapter: Depression and Bipolar Disorder in Adolescence

  1. Assess for signs and symptoms consistent with either depressive disorder or bipolar disorder in adolescents.
  2. Distinguish mood disorder from other mental health disorders in adolescents.
  3. Develop a treatment regimen consisting of nonpharmacologic and pharmacologic therapies for depressive disorders in an adolescent patient.
  4. Design a comprehensive treatment plan for an adolescent patient diagnosed with bipolar disorder.
  5. Analyze available resources to aid adolescent patients, families, and caregivers. 

Chapter: Rheumatology: Juvenile Idiopathic Arthritis

  1. Distinguish the difference between juvenile idiopathic arthritis (JIA) classifications.
  2. Design appropriate guideline-directed pharmacologic therapy for a patient on the basis of JIA classification, assess treatment response, and adjust therapy on the basis of response.
  3. Develop a treatment plan containing a conventional synthetic disease-modifying antirheumatic drug (DMARD), and recommend a dose, route of administration, and monitoring values for a patient with oligoarthritis.
  4. Develop a treatment plan containing an appropriate biologic DMARD, and recommend a dose, route of administration, and monitoring values for a patient with JIA.
  5. Plan a course of therapy for a patient with systemic JIA, including monitoring for drug response and need for discontinuation.
  6. Create a vaccination plan for both live and inactivated vaccines, including SARS-CoV-2. 

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 3

Activity Number: 0217-9999-23-105-H01-P
Contact Hour(s): 3.50
Activity Type: Application Based
Learning Objectives

Chapter: Geriatric Syndromes

  1. Evaluate and distinguish the concept “geriatric syndrome” from other medical disorders.
  2. Assess the most common geriatric syndromes in the ambulatory older adult population.
  3. Classify the major risk factors and known etiologies of selected geriatric syndromes.
  4. For each of the most common ambulatory care–related geriatric syndromes, analyze assessment tools and current treatment intervention recommendations.
  5. Assess the impact of geriatric syndromes on the health status of the older adult and the challenge they present in the provision of health care.
  6. Evaluate the pharmacist’s role in the care of ambulatory older adults with geriatric syndromes. 

Chapter: Arthritis in Older Adults: Osteoarthritis, Rheumatoid Arthritis, and Gout

  1. Discover the impact and presentation of osteoarthritis (OA), rheumatoid arthritis (RA), and gout in the older adult population.
  2. Apply recent guidelines to older adults experiencing OA, RA, and gout.
  3. Construct a pharmacologic treatment plan for older adults with arthritis caused by OA, RA, or gout.
  4. Develop a monitoring plan for older adults with arthritis caused by OA, RA, or gout.
  5. Assess vaccination considerations and social determinants of health on the treatment of OA, RA, or gout.

ACSAP 2023 Book 2, Geriatric and Pediatric Care, Module 4

Activity Number: 0217-9999-23-106-H01-P
Contact Hour(s): 3.50
Activity Type: Application Based
Learning Objectives

Interactive Case: Attention-Deficit/Hyperactivity Disorder and Anxiety

  1. Evaluate the signs and symptoms associated with attention-deficit/hyperactivity disorder (ADHD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth EditionText Revised (DSM-5-TR) and classify whether an adolescent patient meets the criteria for diagnosis.
  2. Distinguish anxiety symptoms in an adolescent patient diagnosed with ADHD and be able to differentiate anxiety from inattention, hyperactivity, and/or impulsivity.
  3. Design a pharmacologic treatment plan for an adolescent patient diagnosed with ADHD and concomitant generalized anxiety disorder.
  4. Evaluate the adverse effects, monitoring values, and contraindications associated with the pharmacologic agents used to treat ADHD and concomitant generalized anxiety disorder.
  5. Justify the benefits of ADHD pharmacotherapy for patients and family members who may be concerned about the adverse effects associated with these medications. 

Interactive Case: Prescribing Cascades/Deprescribing in Older Adults

  1. Evaluate an older adult’s medication regimen for opportunities to de-escalate therapies used for chronic diseases.
  2. Distinguish patient characteristics of those who may benefit from continuing or discontinuing preventive therapies.
  3. Develop a treatment regimen for deprescribing medications safely, including weans or alternative therapies.
  4. Justify treatment choices for deprescribing using evidence-based medicine.
  5. Assess a medication regimen for potential drug-induced adverse events to avoid the prescribing cascade.
  6. Develop a strategy to communicate deprescribing recommendations to prescribers and patients. 

Interactive Case: Fall Prevention and Osteoporosis in Older Adults

  1. Classify the incidence, risk factors, and potential complications of falls and osteoporosis in older adults.
  2. Design a comprehensive care plan for falls prevention and osteoporosis management according to patient-specific characteristics and risk factors.
  3. Develop a comprehensive monitoring plan for osteoporosis management according to goals of therapy.
  4. Assess patient social determinants of health that may affect older adults at risk of falling and/or with osteoporosis. 

Disclosures


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

Documents Click on a document to view/download.

Sample Chapter